org placeholder image

Adam Camblin

Associate Director, Non-Clinical Development at Beam Therapeutics

  • LinkedIn

Pharmaceutical scientist with 10+ years’ experience in the hematology / oncology sector committed to improving the lives of patients and their families through precise execution of rigoro...

Read More

map
BEAM THERAPEUTICS

BEAM THERAPEUTICS

  • description Description
    Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows...

    Read More

  • Employees count Employees 501-1000
  • Revenue Revenue 50 Million to 100 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Beam Therapeutics Org Chart and Mapping

Employees

Frequently Asked Questions Regarding Adam Camblin

Answer: Adam Camblin works for Beam Therapeutics as Associate Director, Non-Clinical Development

Answer: Adam Camblin’s role in Beam Therapeutics is Associate Director, Non-Clinical Development

Answer: Adam Camblin's email address is a***@gmail.com

Answer: Adam Camblin's business email address is a****@merrimackpharma.com

Answer: Adam Camblin’s direct phone number is (***)-***-****

Answer: Adam Camblin works in the industry of: Biotechnology

Answer: Adam Camblin is the current Associate Director, Non-Clinical Development at Beam Therapeutics.... Read More

Answer: Adam Camblin works Beam Therapeutics located at 238 Main St Ste 9, Cambridge, Massachusetts, 02142, United States

Answer: Beam Therapeutics's Associate Director, Non-Clinical Development is Adam Camblin

Answer: Adam Camblin contact details:

  • Phone number  :  (***)-***-****
  • Email  :  a****@merrimackpharma.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access